X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
male (73) 73
index medicus (58) 58
prostate cancer (58) 58
oncology (54) 54
immunotherapy (53) 53
immunology (43) 43
article (37) 37
prostatic neoplasms - immunology (35) 35
animals (33) 33
human necessities (33) 33
hygiene (33) 33
medical or veterinary science (33) 33
preparations for medical, dental, or toilet purposes (33) 33
cancer (31) 31
middle aged (27) 27
prostatic neoplasms - therapy (27) 27
aged (24) 24
dna vaccine (22) 22
testing (22) 22
investigating or analysing materials by determining theirchemical or physical properties (21) 21
measuring (21) 21
mice (21) 21
physics (21) 21
cancer vaccines - immunology (20) 20
chemistry (20) 20
dendritic cells (20) 20
metallurgy (20) 20
adult (19) 19
antigen (19) 19
peptides (18) 18
sipuleucel-t (18) 18
t cells (18) 18
care and treatment (17) 17
female (16) 16
research (16) 16
vaccines (16) 16
vaccines, dna - immunology (16) 16
antigens (15) 15
antigens, neoplasm - immunology (15) 15
prostatic acid phosphatase (15) 15
acid-phosphatase (14) 14
immunization (14) 14
prostatic neoplasms - pathology (14) 14
urology & nephrology (14) 14
immune-responses (13) 13
tumors (13) 13
antibody (12) 12
cd8-positive t-lymphocytes - immunology (12) 12
clinical trials (12) 12
colony-stimulating factor (12) 12
expression (12) 12
immunological efficacy (12) 12
organic chemistry (12) 12
prostatic neoplasms - drug therapy (12) 12
vaccine (12) 12
cell line, tumor (11) 11
dna (11) 11
enzyme-linked immunosorbent assay (11) 11
immunotherapy - methods (11) 11
lymphocytes (11) 11
medicine, research & experimental (11) 11
treatment outcome (11) 11
vaccination (11) 11
cancer vaccines (10) 10
dna vaccines (10) 10
health aspects (10) 10
induction (10) 10
phase-i trial (10) 10
responses (10) 10
acid phosphatase (9) 9
aged, 80 and over (9) 9
endocrinology & metabolism (9) 9
immunity (9) 9
immunoglobulin g - blood (9) 9
medicine & public health (9) 9
rats (9) 9
t-cell responses (9) 9
t-lymphocytes - immunology (9) 9
antibodies (8) 8
cancer vaccines - administration & dosage (8) 8
cancer vaccines - therapeutic use (8) 8
clinical trials as topic (8) 8
immune response (8) 8
immunoglobulin g - immunology (8) 8
melanoma (8) 8
metastasis (8) 8
prostate-specific antigen - blood (8) 8
prostate-specific antigen - immunology (8) 8
specific therapeutic activity of chemical compounds ormedicinal preparations (8) 8
t-cells (8) 8
adenocarcinoma - immunology (7) 7
cancer research (7) 7
castration (7) 7
cells (7) 7
epitopes, t-lymphocyte - immunology (7) 7
in-vivo (7) 7
lymphocytes t (7) 7
medical research (7) 7
neoplasm metastasis (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2360 - 2360
Background: Plasmid DNA vaccination is a safe and economical vaccine modality that has been demonstrated to elicit cellular and humoral immunity in preclinical... 
Journal Article
Cancer, ISSN 0008-543X, 12/2016, Volume 122, Issue 23, pp. 3598 - 3607
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2362 - 2362
Through early phase clinical trials we have shown that a plasmid DNA vaccine can elicit antigen-specific CD8 T-cells that can persist for years. However, the... 
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1423 - 1423
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3945 - 3945
We have reported the results of two phase I trials using a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with biochemically recurrent... 
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 2502 - 2502
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 10/2016, Volume 57, Issue 10, pp. 1487 - 1487
Immunotherapy has emerged as a promising alternative in the arsenal against cancer by harnessing the power of the immune system to specifically target... 
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 10/2016, Volume 57, Issue 10, p. 1487
  Immunotherapy has emerged as a promising alternative in the arsenal against cancer by harnessing the power of the immune system to specifically target... 
Nuclear medicine | Molecules | Medical imaging | Immunotherapy | Cancer | Immune system
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 12/2015, Volume 14, Issue 12 Supplement 2, pp. CN04-03 - CN04-03
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7_suppl, pp. 168 - 168
168 Background: We have previously investigated a DNA vaccine encoding prostatic acid phosphatase (PAP, pTVG-HP) in patients with PSA-recurrent prostate... 
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 243 - 243
Journal Article
Prostate, ISSN 0270-4137, 08/2012, Volume 72, Issue 11, pp. 1239 - 1247
Journal Article
CANCER IMMUNOLOGY IMMUNOTHERAPY, ISSN 0340-7004, 10/2011, Volume 60, Issue 10, pp. 1447 - 1460
Prior to the advent of VEGF-targeted therapies, renal cell carcinoma (RCC) was among the few solid tumors shown to respond to cytokine-based therapies such as... 
SURVIVAL | Interleukin-2 | BISPHOSPHONATE | RECEPTOR | TUMOR-CELLS | RECOMBINANT INTERLEUKIN-2 | IMMUNOLOGY | INTERFERON-ALPHA | THERAPY | ONCOLOGY | V gamma 9 V delta 2 lymphocyte | Renal cell carcinoma | IMMUNOTHERAPY | IN-VIVO | Zoledronic acid | DIFFERENTIATION
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 4, pp. e59 - e59
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 5384 - 5384
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 11/2012, Volume 10, Issue 11, pp. 716 - 722
Approximately 35% of prostate cancer patients will experience a biochemical recurrence within 10 years of receiving treatment. Among patients who develop... 
Prostatespecific antigen | Androgen-deprivation therapy | Biochemical recurrence | Prostate cancer | Recurrence | Humans | Androgen Antagonists - therapeutic use | Male | Clinical Trials as Topic | Combined Modality Therapy | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - therapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.